Page last updated: 2024-09-04

edotreotide and Experimental Neoplasms

edotreotide has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eltschinger, V; Reubi, JC; Schottelius, M; Schwaiger, M; Wester, HJ1
Alke, A; Essler, M; Henriksen, G; Miederer, M; Mossbrugger, I; Quintanilla-Martinez, L; Senekowitsch-Schmidtke, R1

Other Studies

2 other study(ies) available for edotreotide and Experimental Neoplasms

ArticleYear
N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.
    Journal of medicinal chemistry, 2005, Apr-21, Volume: 48, Issue:8

    Topics: Animals; Biological Transport; Cell Line; Cricetinae; Cricetulus; Female; Glucose; Glycosylation; Humans; Iodine Radioisotopes; Isotope Labeling; Ligands; Maltose; Mice; Mice, Nude; Neoplasms, Experimental; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Structure-Activity Relationship; Trisaccharides

2005
Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jun-01, Volume: 14, Issue:11

    Topics: Alpha Particles; Animals; Mice; Mice, Nude; Neoplasms, Experimental; Neuroendocrine Tumors; Octreotide; Radioisotopes; Radiopharmaceuticals; Rats; Receptors, Somatostatin; Xenograft Model Antitumor Assays

2008